Morning Movers 8/17: ISR, HURN, POR, QGLY, TSEM, NVAX, CHINA Higher; RPRX, GERN, DFG Lower

IsoRay, Inc. (Amex: ISR) <font>95.7% HIGHER;</font> announced that it has received clearance from the FDA for its Premarket Notification, [510(k)] for Proxcelan(TM) Cesium-131 Brachytherapy Seeds enabling the company to preload Cesium-131 into flexible braided strands and surgical mesh. This FDA clearance allows IsoRay to market Cesium-131 seeds for use in the treatment of cancers well beyond the current prostate market. Click here for the full report.

Huron Consulting Group Inc. (NASDAQ: HURN) <font>27.5% HIGHER;</font> reports Q2 non-GAAP EPS of $0.84, versus $1.06 reported in the same quarter last year. Revenue for the quarter was $165.8 million, versus the